HIV Vaccines and Cure: The Path Towards Finding an Effective Cure and Vaccine: Advances in Experimental Medicine and Biology, cartea 1075
Editat de Linqi Zhang, Sharon R. Lewinen Limba Engleză Paperback – 29 dec 2018
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 927.24 lei 6-8 săpt. | |
Springer Nature Singapore – 29 dec 2018 | 927.24 lei 6-8 săpt. | |
Hardback (1) | 933.10 lei 6-8 săpt. | |
Springer Nature Singapore – 2 aug 2018 | 933.10 lei 6-8 săpt. |
Din seria Advances in Experimental Medicine and Biology
- 60% Preț: 316.29 lei
- 5% Preț: 1091.25 lei
- 20% Preț: 691.93 lei
- 5% Preț: 702.52 lei
- 5% Preț: 702.52 lei
- 5% Preț: 700.90 lei
- 5% Preț: 701.80 lei
- 5% Preț: 239.86 lei
- Preț: 642.95 lei
- 5% Preț: 820.42 lei
- 5% Preț: 701.24 lei
- 15% Preț: 627.29 lei
- 15% Preț: 628.41 lei
- 5% Preț: 1010.11 lei
- 5% Preț: 701.80 lei
- 5% Preț: 702.71 lei
- 20% Preț: 1138.16 lei
- 5% Preț: 1146.80 lei
- 18% Preț: 1097.18 lei
- 5% Preț: 1262.34 lei
- 5% Preț: 1141.07 lei
- 5% Preț: 1079.41 lei
- 18% Preț: 1100.89 lei
- 5% Preț: 1406.52 lei
- 20% Preț: 1022.93 lei
- 18% Preț: 927.20 lei
- 5% Preț: 292.57 lei
- 18% Preț: 938.22 lei
- 18% Preț: 1210.67 lei
- 5% Preț: 1206.58 lei
- 5% Preț: 1266.09 lei
- 5% Preț: 1079.77 lei
- 18% Preț: 1109.85 lei
- 5% Preț: 1141.57 lei
- 5% Preț: 1389.69 lei
- 5% Preț: 1279.16 lei
- 18% Preț: 1388.96 lei
- 18% Preț: 1384.32 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1218.07 lei
- 5% Preț: 1400.44 lei
- 5% Preț: 1585.87 lei
- 5% Preț: 1278.66 lei
- 18% Preț: 1102.11 lei
- 5% Preț: 1075.31 lei
- 15% Preț: 636.73 lei
- 5% Preț: 1075.31 lei
- 18% Preț: 926.63 lei
Preț: 927.24 lei
Preț vechi: 1130.79 lei
-18% Nou
Puncte Express: 1391
Preț estimativ în valută:
177.47€ • 184.47$ • 147.01£
177.47€ • 184.47$ • 147.01£
Carte tipărită la comandă
Livrare economică 04-18 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811344282
ISBN-10: 9811344280
Pagini: 336
Ilustrații: XV, 318 p. 21 illus., 16 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer Nature Singapore
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:Singapore, Singapore
ISBN-10: 9811344280
Pagini: 336
Ilustrații: XV, 318 p. 21 illus., 16 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer Nature Singapore
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:Singapore, Singapore
Cuprins
HIV Vaccine Efficacy Trials: RV144 and beyond.- HIV T-cell vaccines.- HIV broadly neutralizing antibodies: VRC01 and beyond.- Structural features of broadly neutralizing antibodies and rational design of vaccine.- Monkey models and HIV vaccine research.- Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level.- HIV persistence on antiretroviral therapy and barriers to a cure.- The molecular biology of HIV latency.- Cellular determinants of HIV persistence on antiretroviral therapy.- In Vitro and In Vivo Models of HIV Latency.- Measuring HIV persistence on antiretroviral therapy.- Clinical interventions in HIV cure research
Notă biografică
Dr. Linqi Zhang is a professor of Department of Basic Medical Sciences, and the director of Comprehensive AIDS Research Center, Tsinghua University. He is also an adjunct professor of Peking Union Medical College, China. Prof. Zhang was the Chief Scientist for the National Key Basic Research Projects of China “HIV Biology and its Immune Responses”. His research focuses on pathogenesis of HIV-1 and vaccine development against HIV-1. He has published more than 100 research articles on international journals in this field.
Dr. Sharon Lewin is a professor of Medicine at the University of Melbourne and the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and Royal Melbourne Hospital. She is a consultant physician at the Alfred Hospital and a practitioner fellow funded by the National Health and Medical Research Council of Australia. Prof. Lewin’s research focuses on understanding how HIV persists on antiretroviral therapy, developing early clinical trials to achieve a cure for HIV and understanding how HIV interacts with other viruses such as hepatitis B virus. She has published more than 250 research articles in these fields.
Dr. Sharon Lewin is a professor of Medicine at the University of Melbourne and the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and Royal Melbourne Hospital. She is a consultant physician at the Alfred Hospital and a practitioner fellow funded by the National Health and Medical Research Council of Australia. Prof. Lewin’s research focuses on understanding how HIV persists on antiretroviral therapy, developing early clinical trials to achieve a cure for HIV and understanding how HIV interacts with other viruses such as hepatitis B virus. She has published more than 250 research articles in these fields.
Textul de pe ultima copertă
This book provides a comprehensive review of the major barriers to HIV cure and vaccine. It covers the fundamental virology and immunology leading to HIV transmission, protection from infection and long term HIV persistence on antiretroviral therapy. In addition, strategies being tested to eliminate persistent HIV and the rational design of vaccines to induce protective immunity are covered. This book also discusses the challenges related to the design of clinical trials for testing the safety and efficacy of these innovative approaches. This book will provide a systematic overview and also discuss controversial issues for researchers in virology and immunology, as well as practicing physicians, and scientists in the pharmaceutical industry.
Caracteristici
Providing a comprehensive review of the major barriers to HIV cure and vaccine Covering the fundamental virology and immunology of HIV Discussing the challenges related to development of HIV vaccine and its clinical trials